Pancreatic Cancer Research

ResearcherKitasato University HospitalActive in the last 2 years

Kai Adachi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4657-2736; OpenAlex author ID A5087300261. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 3 papers · 2023: none · 2024: 4 papers

Papers 8

  1. High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study. Co-author DOI 10.1007/s13691-024-00715-0↗
  2. REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Co-author DOI 10.1111/cas.16044↗
  3. Efficacy of endoscopic ultrasound-guided tissue acquisition using stereo-microscopic on-site evaluation for possible comprehensive genome profile in patients w… Co-author DOI 10.1111/jgh.16478↗
  4. Effectiveness of endoscopic ultrasound-guided tissue acquisition with stereomicroscopic on-site evaluation for preoperative diagnosis of resectable or borderli… Co-author DOI 10.5946/ce.2023.277↗
  5. New image-processing technology for endoscopic ultrasound-guided fine-needle aspiration biopsy specimen evaluation in patients with pancreatic cancer. Co-author DOI 10.1002/deo2.21↗
  6. CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer. Co-author DOI 10.1007/s00428-021-03230-2↗
  7. Clinicopathological Significance of BRCAness in Resectable Pancreatic Ductal Adenocarcinoma and Its Association With Anticancer Drug Sensitivity in Pancreatic … Co-author DOI 10.1097/mpa.0000000000001975↗
  8. Analysis of BRCAness with multiplex ligation-dependent probe amplification using formalin-fixed and paraffin-embedded pancreatic ductal adenocarcinoma tissue o… Co-author DOI 10.1016/j.pan.2019.02.010↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masayoshi Tadehara · 6 shared papers, 2019–2024 · strength 0.89
  2. Kosuke Okuwaki · 5 shared papers, 2019–2024 · strength 0.82
  3. Masafumi Watanabe · 5 shared papers, 2019–2024 · strength 0.82
  4. Akihiro Tamaki · 5 shared papers, 2022–2024 · strength 0.81
  5. Chika Kusano · 4 shared papers, 2024 · strength 0.78
  6. Taro Hanaoka · 3 shared papers, 2024 · strength 0.60
  7. Wasaburo Koizumi · 4 shared papers, 2019–2022 · strength 0.52
  8. Yoshiki Murakumo · 3 shared papers, 2022–2024 · strength 0.47
  9. Takahiro Kurosu · 3 shared papers, 2019–2024 · strength 0.41
  10. Junro Ishizaki · 2 shared papers, 2024 · strength 0.39
  11. Rikiya Hasegawa · 2 shared papers, 2022–2024 · strength 0.32
  12. Yusuke Kumamoto · 1 shared paper, 2024 · strength 0.21
  13. Nobuyuki Nishizawa · 1 shared paper, 2024 · strength 0.21
  14. Shinji Mii · 1 shared paper, 2022 · strength 0.14
  15. Atsushi Enomoto · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.